Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (10): 93-100.doi: 10.6040/j.issn.1671-7554.0.2019.850
Previous Articles Next Articles
ZHAO Yani, LUAN Xiaorong, LI Haiyan
CLC Number:
| [1] Abla AA, Gandhoke G, Clark JC, et al. Surgical outcomes for moyamoya angiopathy at barrow neurological institute with comparison of adult indirect encephaloduroarteriosynangiosis bypass, adult direct superficial temporal artery-to-middle cerebral artery bypass, and pediatric bypass: 154 revascularization surgeries in 140 affected hemispheres [J]. Neurosurgery, 2013, 73(3): 430-439. [2] Fujimura M, Bang OY, Kim JS. Moyamoya Disease [J]. Front Neurol Neurosci, 2016, 40: 204-220. [3] Bao XY, Duan L, Yang WZ, et al. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China [J]. Cerebrovasc Dis, 2015, 39(2): 75-81. [4] Kang S, Liu X, Zhang D, et al. Natural course of moyamoya disease in patients with prior hemorrhagic stroke [J]. Stroke, 2019, 50(5): 1060-1066. [5] Bower RS, Mallory GW, Nwojo M, et al. Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease [J]. Stroke, 2013, 44(7): 1997-1999. [6] Li Q, Gao Y, Xin W, et al. Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease [J]. World Neurosurg, 2019, 127: 354-361. doi: 10.1016/j.wneu.2019.04.062. [7] Acker G, Fekonja L, Vajkoczy P. Surgical management of moyamoya disease [J]. Stroke, 2018, 49(2): 476-482. [8] Kim T, Oh CW, Bang JS, et al. Moyamoya disease: treatment and outcomes [J]. J Stroke, 2016, 18(1): 21-30. [9] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J]. 中华神经科杂志, 2010, 43(2): 4013-4017. Chinese Medical Association Neurology Society Cerebral Vascular Society Cerebral Ischemic Stroke Diagnosis and Treatment Guidelines Writing Group. China Acute Ischemic Stroke Diagnosis and Treatment Guidelines 2010 [J]. Chinese Journal of Neurology, 2010, 43(2): 4013-4017. [10] Kazumata K, Ito M, Tokairin K, et al. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review [J]. J Neurosurg, 2014, 121(2): 432-440. [11] Funaki T, Takahashi JC, Takagi Y, et al. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications [J]. J Neurosurg, 2015, 122(2): 400-407. [12] Zhao M, Deng X, Zhang D, et al. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease [J]. J Neurosurg, 2018, 1: 1-12. doi: 10.3171/2017.10.JNS171749. [13] Zhao M, Deng X, Gao F, et al. Ischemic stroke in young adults with moyamoya disease: prognostic factors for stroke Recurrence and Functional Outcome after Revascularization [J]. World Neurosurg, 2017, 103: 161-167. doi: 10.1016/j.wneu.2017.03.146. [14] Ge P, Zhang Q, Ye X, et al. Clinicalfeatures, surgical treatment, and long-term outcome in elderly patients with moyamoya disease [J]. World neurosurg, 2017, 100: 459-466. doi: 10.1016/j.wneu.2017.01.055. [15] Park W, Ahn JS, Lee HS, et al. Risk factors for newly developed cerebral infarction after surgical revascularization for adults with moyamoya disease [J]. World Neurosurg, 2016, 92: 65-73. doi: 10.1016/j.wneu.2016.03.053. [16] Wei W, Chen X, Yu J, et al. Risk factors for postoperative stroke in adult patients with moyamoya disease: a systematic review with meta-analysis [J]. BMC Neurology, 2019, 19(1): 98-105. [17] 班峰. 围手术期卒中的风险评估、预防及治疗[D]. 石家庄:河北医科大学, 2017: 1-23. [18] Kim S, Choi J, Yang K, et al. Risk factors for postoperative ischemic complications in patients with moyamoya disease [J]. J Neurosurg, 2005, 103(5 Suppl): 433-440. [19] 鲁志科, 孙榕. 高血压病患者降压治疗前后颈、股动脉弹性改善程度的研究[J]. 湖南师范大学学报(医学版), 2019, 16(2): 105-108. LU Zhike, SUN Rong. Study on the improvement of the elasticity of the carotid and femoral artery before and after hypertension treatment [J]. Journal of Hunan Normal University(Health Sciences), 2019, 16(2): 105-108. [20] Noh HJ,Kim SJ,Kim JS,et al. Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease [J]. Journal of the Neurological Sciences, 2015, 359(1-2): 381-388. [21] 张苗怡, 唐杰, 刘娜, 等. 血管重建术对不同类型烟雾病患者卒中复发及功能预后的影响[J]. 复旦学报(医学版), 2018, 45(4): 478-484. ZHANG Miaoyi, TANG Jie, LIU Na, et al. Effects of revascularization on recurrence and functional prognosis of patients with moyamoya disease [J]. Journal of Fudan University(Health Sciences), 2018, 45(4): 478-484. [22] 任斌. 烟雾病伴发Ⅱ型糖尿病的临床表现及其脑血管重建的特征[D]. 北京:中国人民解放军军事医学科学院, 2016: 1-92. [23] 朱爱群, 张静平, 邹婷, 等. 血压、血糖、血脂与不同年龄、性别脑卒中的相关性[J]. 中南大学学报(医学版), 2014, 39(12): 1271-1278. ZHU Aiqun, ZHANG Jingping, ZOU Ting, et al. Correlation of blood pressure, blood glucose and blood lipid with stroke of different age and sex[J]. Journal of Central South University(Health Sciences), 2014, 39(12): 1271-1278. [24] Ren B, Zhang ZS, Liu WW, et al. Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes [J]. J neurosurg, 2016, 125(2): 308-314. [25] Li J, Zhao Y, Zhao M, et al. High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease[J]. Neurosurg Rev, 2019, 15. doi: 10.1007/s10143-019-01118-z. [26] 吴彦. 高血压患者在围术期的血压控制要点[J]. 中国医学前沿杂志(电子版), 2014, 6(4): 9-12. WU Yan. Key points of blood pressure control in patients with hypertension during perioperative period [J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2014, 6(4): 9-12. [27] 中国高血压防治指南修订委员会高血压联盟, 中华医学会心血管病学分会, 中国医师协会高血压专业委员会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56. China Hypertension Prevention and Treatment Guidelines Revision Committee Hypertension League, Chinese Medical Association Cardiovascular Branch, Chinese Medical Association Hypertension Professional Committee, etc. China Guidelines for Prevention and Treatment of Hypertension(Revised Edition, 2018)[J]. Chinese Journal of Cardiology, 2019, 24(1): 24-56. [28] Sato K, Shirane R, Yoshimoto T. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease [J]. Childs Nerv Syst, 1997, 13(2): 68-72. [29] Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease [J]. Neurosurgery, 1996, 38(6): 1120-1125. |
| [1] | LIU Huijun, WU Zhaoting, WANG Yuli, XU Mingyang, LIU Xiao, KANG Yan, WANG Hongmei. Risk factors and early intervention for postpartum hemorrhage caused by lower uterine segment atony [J]. Journal of Shandong University (Health Sciences), 2026, 64(5): 61-66. |
| [2] | HUANG Yuzhen, LYU Chen, YAN Lei, LI Shuaishuai, ZHANG Jingxue, LIU Chao, WANG Yinxia, SANG Yanyan, FANG Mei. Preventive effects of continued out-of-hospital management based on risk factor screening for ovarian hyperstimulation syndrome [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 92-99. |
| [3] | PANG Jinhong, SU Ping, QIAO Junpeng, CHEN Qiaoqiao, CHEN Xueyu, ZHAO Yingying, SHI Jie, SUN Xiaoru, LI Qiuchun, HE Ruiyan, FAN Yiou, CHI Weiwei. Association between modifiable cardiovascular risk factors clustering patterns and stroke in the elderly population [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 11-19. |
| [4] | GUO Ke, CHEN Xujun, SHI Chao, LUO Junhui, YANG Min, WANG Xiaowu, WANG Zhendong, LI Youjin, MENG Chunying, CHEN Wensheng. Outcomes of a Y-composite arterial graft using free right internal mammary artery and radial artery for patients undergoing total arterialization myocardial revascularization in multi-center in China [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 84-91. |
| [5] | XU Ruize, WANG Jinlan, LUO Qingxin, XU Zhaoke, LYU Mingyue, ZHANG Shuo, YAN Luning, HU Xifeng, ZHAO Qingbo, ZHU Gaopei, LI Lei, XUE Fuzhong. Risk of recurrent acute coronary syndrome associated with coronary revascularization [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 103-110. |
| [6] | ZHANG Zheng, WANG Jianwei, YANG Yujuan, ZHANG Yu, SONG Xicheng. Immunoglobulin E changes and risk factors in asthma children between 2008 and 2019 [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 32-36. |
| [7] | JIA Ruoxi, LYU Li, LIU Hanyun, WU Yinping, LI Fengcai, ZHAO Zehua, WANG Kai, FAN Yuchen. Diagnostic value of blood cell count-related biomarkers in predicting 28-day mortality in acute-on-chronic hepatitis b liver failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 89-99. |
| [8] | CHEN Xujun, HE Guowei. Focus on further more use of arterial grafts in coronary artery bypass grafting in patients with coronary heart disease in China [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 1-5. |
| [9] | CHEN Xujun, SHEN Lin, CHEN Jun, YU Tao, CAO Guangqing, XIAO Fei. Anatomic complete revascularization is a new strategy of surgical treatment for coronary heart disease [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 12-17. |
| [10] | GUO Ke, CHEN Xujun, ZHENG Baoshi, HUANG Keli, WANG Xiaowu, CHEN Jingwei, LIN Yu, LUO Junhui, WANG Haichen, WANG Zhendong, LIAO Chengquan, LI Youjin, CHEN Wensheng. Multi-center mid-term clinical outcomes in coronary patients undergoing total arterial bypass surgery with anatomic complete revascularization in China [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 18-25. |
| [11] | GUO Ke, CHEN Xujun, ZHENG Baoshi, SHI Chao, HUANG Keli, CAO Yong, CHEN Jun, WU Dongkai, ZHANG Xiaoshen, LUO Junhui, SHEN Lin, MO Xumin, YANG Min, WANG Xiaowu, LEI Yinsheng, TIAN Maozhou, WANG Zhendong, MENG Zili, SUN Zhongdong, LI Youjin, LU Huihui, MENG Chunying, GAO Feng, CHEN Qiansu, GUO Nengrui, LIU Debin, ZHANG Nan, LIN Yu, CHEN Wensheng, SONG Baoguo, FANG Zhi, WANG Haichen, LIAO Xiaobo, XU Chaojun. Multi-center clinical outcomes of fast-track extubation in total arterial coronary bypass grafting in China [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 26-32. |
| [12] | LI Jing, HAO Panpan. Association between the heart rate variation and the prognosis in patients with acute heart failure at hospital admission and discharge [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 75-82. |
| [13] | CHENG Zhenyu, LAI Qingguo, WU Mengtao. Advances in influencing factors of in-stent restenosis after iliofemoral vein stenting [J]. Journal of Shandong University (Health Sciences), 2025, 63(12): 112-117. |
| [14] | CHENG Yueqi, WANG Fei, YU Lixiang, ZHENG Chao, YU Zhigang. Progress in the study of trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 17-24. |
| [15] | GAO Jianfeng, LI Fangda, WU Lianglin, ZENG Rong, ZHENG Yuehong. Progress in diagnosis and treatment of immune disease related aortic lesions [J]. Journal of Shandong University (Health Sciences), 2024, 62(9): 30-35. |
|
||